CHOP Develops an Automated Screening Tool to Identify Cancer Patients for Malnutrition Published on Oct 10, 2018 in CHOP News, Cancer Connections CHOP’s pediatric malnutrition screening tool could be implemented to screen all pediatric patients.
No More Kids with Cancer Awards $220,000 to CHOP Published on Oct 05, 2018 in CHOP News The $220,000 award will be directed to a Phase I clinical trial that will investigate the effectiveness of CAR T-cell therapy to treat AML.
2018 Parkway Run & Walk Raises Record-breaking $1.38 Million Published on Oct 02, 2018 in CHOP News Proceeds from the event will support breakthroughs in pediatric cancer research and care at Children's Hospital of Philadelphia.
Pediatric Cancer Cell Therapy: What’s on the Horizon Published on Oct 01, 2018 in Cancer Connections Trials of more game-changing cell therapies for pediatric cancer and other diseases are underway or on the horizon at Children's Hospital of Philadelphia.
Hyundai Hope on Wheels Presents CHOP with $500,000 Grant Published on Sep 28, 2018 in CHOP News Hyundai Hope on Wheels Awards CHOP with Hyundai Hope Scholar and Young Investigator Grant to support pediatric cancer research.
CBS3 Features CHOP Patient Kissed by Pope Published on Sep 17, 2018 in CHOP News CHOP patient family credits faith and doctors for recovery and donates $50,000 to Children's Hospital of Philadelphia.
CHOP-Led Gabriella Miller Kids First Data Resource Center Launches New NIH-Funded Childhood Disease Research Portal Published on Sep 10, 2018 in CHOP News The new research platform will make large-scale data on childhood cancer and birth defects available to researchers, clinicians and patients within a cloud-based environment.
Parents Magazine Names Children’s Hospital of Philadelphia Among 20 Most Innovative Children’s Hospitals Published on Sep 05, 2018 in CHOP News Children’s Hospital of Philadelphia was recognized specifically for significant contributions to the development of a new treatment for a certain pediatric leukemia.
European Commission Approves Innovative CAR T-cell Therapy Pioneered at Children’s Hospital of Philadelphia Published on Aug 24, 2018 in CHOP News The European Commission (EC) approves Kymriah, the first-ever U.S. FDA approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers.
Recent FDA Approval Opens New Possibilities for CAR T-cell Therapies Published on Jul 31, 2018 in Children's Doctor CHOP has been at the forefront of developing cell therapy to treat ALL. Some next steps include initiating clinical trials for AML and, ultimately, making this treatment work for solid tumors.